Inhaled Nitric Oxide Delivery Systems for Mechanically Ventilated and Nonintubated Patients: A Review

Overview

Journal Respir Care

Publisher Mary Ann Liebert

Specialty Pulmonary Medicine

Date 2021 May 27

PMID 34039761

Citations 9

Authors

Stefano Gianni

Ryan W Carroll

Robert M Kacmarek

Lorenzo Berra

Affiliations

Soon will be listed here.

Abstract

Nitric oxide (NO) is a biologically active molecule approved for the treatment of pulmonary hypertension in newborn patients. Commercially available NO delivery systems use pressurized cylinders as the source of NO and a sensor to control the concentrations of NO and nitrogen dioxide (NO) delivered. Cylinder-based delivery systems are safe and widely used around the world, but they are bulky, expensive, and reliant on a robust supply chain. In the past few years, novel NO generators and delivery systems have been developed to overcome these limitations. Electric NO generators produce NO from ambient air using high-voltage electrical discharge to ionize air, which leads to the formation of NO, NO, and ozone (O). A scavenging system is incorporated to reduce the concentration of the toxic byproducts generated in this type of system. NO can also be generated by the reduction of NO by ascorbic acid or released from liquid solutions or solid nanoparticles. The development of easy-to-use, safe, and portable NO delivery systems may enable the delivery of NO in the out-patient setting or at home. Furthermore, non-cylinder-based NO generators reduce the cost of NO production and storage and may therefore make NO delivery feasible in low-resource settings. Here we review commercially available systems that can generate and administer inhalable NO.

Citing Articles

Feasibility of controlled nitric oxide generation ascorbate induced chemical reduction of nitrite ions.

Naldrett H, Fekete C, Bartlett R, Benko Z, Schwendeman S, Lautner G Dalton Trans. 2024; 54(5):1797-1805.

PMID: 39569571 PMC: 11579995. DOI: 10.1039/d4dt01980f.

A novel, cassette-based nitric oxide delivery system with an advanced feedback control algorithm accurately delivers nitric oxide via the anesthesia machine independent of fresh gas flow rate and volatile anesthetic agent.

Twite M, Roebuck A, Anderson S J Clin Monit Comput. 2024; 38(5):1155-1162.

PMID: 38822941 PMC: 11427483. DOI: 10.1007/s10877-024-01143-4.

Administering Nitric Oxide (NO) with High Flow Nasal Cannulas: A Simple Method.

Cousin V, Joye R, Polito A Adv Respir Med. 2024; 92(1):92-95.

PMID: 38392035 PMC: 10886258. DOI: 10.3390/arm92010012.

Development of nitric oxide generators to produce high-dose nitric oxide for inhalation therapy.

Yu B, Wanderley H, Gianni S, Carroll R, Ichinose F, Zapol W Nitric Oxide. 2023; 138-139:17-25.

PMID: 37277062 PMC: 10526742. DOI: 10.1016/j.niox.2023.05.007.

Nitric Oxide in Cardiac Surgery: A Review Article.

Kamenshchikov N, Duong N, Berra L Biomedicines. 2023; 11(4).

PMID: 37189703 PMC: 10135597. DOI: 10.3390/biomedicines11041085.

References

Bender K, Alexander J, Enos J, Skimming J . Effects of inhaled nitric oxide in patients with hypoxemia and pulmonary hypertension after cardiac surgery. Am J Crit Care. 1997; 6(2):127-31. View

Vonbank K, Ziesche R, Higenbottam T, Stiebellehner L, Petkov V, Schenk P . Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax. 2003; 58(4):289-93. PMC: 1746623. DOI: 10.1136/thorax.58.4.289. View

Yu B, Ferrari M, Schleifer G, Blaesi A, Wepler M, Zapol W . Development of a portable mini-generator to safely produce nitric oxide for the treatment of infants with pulmonary hypertension. Nitric Oxide. 2018; 75:70-76. PMC: 5861015. DOI: 10.1016/j.niox.2018.02.006. View

Lovich M, Bruno N, Plant C, Wei A, Vasquez G, Johnson B . Use of ultra pure nitric oxide generated by the reduction of nitrogen dioxide to reverse pulmonary hypertension in hypoxemic swine. Nitric Oxide. 2011; 24(4):204-12. DOI: 10.1016/j.niox.2011.04.006. View

Barrington K, Finer N, Pennaforte T, Altit G . Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017; 1:CD000399. PMC: 6464941. DOI: 10.1002/14651858.CD000399.pub3. View

Todd Tzanetos D, Housley J, Barr F, May W, Landers C . Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Respir Care. 2015; 60(5):644-50. DOI: 10.4187/respcare.03308. View

Privett B, Shin J, Schoenfisch M . Electrochemical nitric oxide sensors for physiological measurements. Chem Soc Rev. 2010; 39(6):1925-35. PMC: 3569000. DOI: 10.1039/b701906h. View

Lovich M, Fine D, Denton R, Wakim M, Wei A, Maslov M . Generation of purified nitric oxide from liquid N2O4 for the treatment of pulmonary hypertension in hypoxemic swine. Nitric Oxide. 2014; 37:66-72. DOI: 10.1016/j.niox.2014.02.001. View

Nathan S, Flaherty K, Glassberg M, Raghu G, Swigris J, Alvarez R . A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis. Chest. 2020; 158(2):637-645. DOI: 10.1016/j.chest.2020.02.016. View

10.

Heinonen E, Hogman M, Merilainen P . Theoretical and experimental comparison of constant inspired concentration and pulsed delivery in NO therapy. Intensive Care Med. 2000; 26(8):1116-23. DOI: 10.1007/s001340051326. View

11.

Frostell C, Blomqvist H, Hedenstierna G, Lundberg J, Zapol W . Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993; 78(3):427-35. DOI: 10.1097/00000542-199303000-00005. View

12.

Taylor R, Zimmerman J, Dellinger R, Straube R, Criner G, Davis Jr K . Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA. 2004; 291(13):1603-9. DOI: 10.1001/jama.291.13.1603. View

13.

Wiegand S, Safaee Fakhr B, Carroll R, Zapol W, Kacmarek R, Berra L . Rescue Treatment With High-Dose Gaseous Nitric Oxide in Spontaneously Breathing Patients With Severe Coronavirus Disease 2019. Crit Care Explor. 2020; 2(11):e0277. PMC: 7671879. DOI: 10.1097/CCE.0000000000000277. View

14.

Miller C, McMullin B, Ghaffari A, Stenzler A, Pick N, Roscoe D . Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure. Nitric Oxide. 2008; 20(1):16-23. DOI: 10.1016/j.niox.2008.08.002. View

15.

Deppisch C, Herrmann G, Graepler-Mainka U, Wirtz H, Heyder S, Engel C . Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study. Infection. 2016; 44(4):513-20. DOI: 10.1007/s15010-016-0879-x. View

16.

Yu B, Muenster S, Blaesi A, Bloch D, Zapol W . Producing nitric oxide by pulsed electrical discharge in air for portable inhalation therapy. Sci Transl Med. 2015; 7(294):294ra107. DOI: 10.1126/scitranslmed.aaa3097. View

17.

Beghetti M, Sparling C, Cox P, Stephens D, Adatia I . Inhaled NO inhibits platelet aggregation and elevates plasma but not intraplatelet cGMP in healthy human volunteers. Am J Physiol Heart Circ Physiol. 2003; 285(2):H637-42. DOI: 10.1152/ajpheart.00622.2002. View

18.

Lei C, Berra L, Rezoagli E, Yu B, Dong H, Yu S . Nitric Oxide Decreases Acute Kidney Injury and Stage 3 Chronic Kidney Disease after Cardiac Surgery. Am J Respir Crit Care Med. 2018; 198(10):1279-1287. PMC: 6290943. DOI: 10.1164/rccm.201710-2150OC. View

19.

Safaee Fakhr B, Wiegand S, Pinciroli R, Gianni S, Morais C, Ikeda T . High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2020; 136(6):1109-1113. PMC: 7673637. DOI: 10.1097/AOG.0000000000004128. View

20.

Friedman A, Han G, Navati M, Chacko M, Gunther L, Alfieri A . Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide. 2008; 19(1):12-20. DOI: 10.1016/j.niox.2008.04.003. View